Osteoclast-activating factor (OAF) is a soluble mediator found in supernates of human peripheral leukocytes which have been cultured with antigens or phytomitogens. OAF is a potent stimulator of osteoclastic resorption of fetal bone in organ culture. The present studies were designed to characterize OAF chemically. Bone resorbing activity from supernates of leukocytes cultured without added plasma was not lost on dialysis using a membrane with a molecular weight cutoff of 3,500, but was lost when heated to 60°C for 30 min. The activity was lost after treatment with trypsin or pronase but not after treatment with ribonuclease or neuraminidase. Papain, which inactivated parathyroid hormone at a concentration of 25 μg/ml, did not inactivate OAF at 250 μg/ml. OAF did not react with an antibody to bovine parathyroid hormone which cross-reacts with human parathyroid hormone. OAF was also distinguished from active metabolites of vitamin D and from prostaglandin by extraction procedures and immunoassay for prostaglandin E2.
Richard A. Luben, Gregory R. Mundy, Clarence L. Trummel, Lawrence G. Raisz
Title and authors | Publication | Year |
---|---|---|
Facing stress and inflammation: From the cell to the planet
Cavaillon JM, Chaudry IH |
World Journal of Experimental Medicine | 2024 |
Reference Module in Biomedical Sciences
DL Sackett, RB Haynes |
2014 | |
Advances in Immunology
E Pinaud, M Marquet, R Fiancette, S Péron, C Vincent-Fabert, Y Denizot, M Cogné |
Advances in Immunology Volume 110 | 2011 |
Bone and Cytokines: Beyond IL-1, IL-6 and TNF-α
A Rifas |
Calcified Tissue International | 1999 |
Platelet-derived growth factor in middle ear cholesteatoma
O Fujioka, CC Huang |
European Archives of Oto-Rhino-Laryngology | 1994 |
Leukemia inhibitory factor (LIF): A growth factor with pleiotropic effects on bone biology
PV Vlasselaer |
Progress in Growth Factor Research | 1992 |
Knochenersatzmittel
JM Rueger |
1992 | |
Induction of bone resorbing activity by normal and rheumatoid arthritis T cells
E Flescher, IR Garrett, GR Mundy, N Talal |
Clinical Immunology and Immunopathology | 1990 |
Cytokines and Osteoporosis
T Fujita, T Matsui, Y Nakao, S Shiozawa, Y Imai |
Annals of the New York Academy of Sciences | 1990 |
Interleukin 1 Causing Bone Destruction in Middle Ear Cholesteatoma
JM Ahn, CC Huang, M Abramson |
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery | 1990 |
The metabolism and immunology of bone
DA Watrous, BS Andrews |
Seminars in Arthritis and Rheumatism | 1989 |
Osteoclasts and Bone Remodeling in Chronic Myeloproliferative Disorders
J Thiele, B Hoeppner, S Wienhold, G Schneider, R Fischer, R Zankovich |
Pathology - Research and Practice | 1989 |
Osteoclast activating factor is now interleukin-1 beta: historical perspective and biological implications
JJ Jandinski |
Journal of Oral Pathology and Medicine | 1988 |
Differentiation of plasma cell infiltrates in the bone marrow: A clinicopathological study on 80 patients including immunohistochemistry and morphometry
J Thiele, B Arenz, H Klein, M Vierbuchen, R Zankovich, R Fischer |
Virchows Archiv A Pathological Anatomy and Histopathology | 1988 |
Calcium in Human Biology
BE Nordin |
1988 | |
Response of osteoblastic clonal cell line (MC3T3-E1) to [Asu1,7]Eel calcitonin at a specific cell density or differentiation stage
N Ito, H Yamazaki, M Nakazaki, T Miyahara, H Kozuka, H Sudo |
Calcified Tissue International | 1987 |
Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors
DR Bertolini, GE Nedwin, TS Bringman, DD Smith, GR Mundy |
Nature | 1986 |
Advances in understanding cell interactions in tissue resorption. Relevance to the pathogenesis of periodontal diseases and a new hypothesis
MC Meikle, JK Heath, JJ Reynolds |
Journal of Oral Pathology and Medicine | 1986 |
Differentiation-inducing factor purified from conditioned medium of mitogen-treated spleen cell cultures stimulates bone resorption
E Abe, H Tanaka, Y Ishimi, C Miyaura, T Hayashi, H Nagasawa, M Tomida, Y Yamaguchi, M Hozumi, T Suda |
Proceedings of the National Academy of Sciences | 1986 |
Inflammatory and immunological aspects of the pathogenesis of human periapical lesions
M Torabinejad, WC Eby, IJ Naidorf |
Journal of Endodontics | 1985 |
Caribbean T-cell lymphoma/leukemia
SH Swerdlow, JA Habeshaw, AZ Rohatiner, TA Lister, AG Stansfeld |
Cancer | 1984 |
Thymus-derived lymphocytes and their interactions with macrophages are required for the production of osteoclast-activating factor in the mouse
M Horowitz, A Vignery, RK Gershon, R Baron |
Proceedings of the National Academy of Sciences | 1984 |
Hypercalc�mie bei malignen Erkrankungen
E Heidbreder, K Schafferhans, A Heidland |
Klinische Wochenschrift | 1983 |
1 alpha,25-dihydroxyvitamin D3 promotes fusion of mouse alveolar macrophages both by a direct mechanism and by a spleen cell-mediated indirect mechanism
E Abe, C Miyaura, H Tanaka, Y Shiina, T Kuribayashi, S Suda, Y Nishii, HF DeLuca, T Suda |
Proceedings of the National Academy of Sciences | 1983 |
Spread of prostatic cancer to bone
SC Jacobs |
Urology | 1983 |
Modulation of chondrocyte synthesis by lymphokine-rich conditioned media
JH Herman, RC Khosla, CS Mowery, AM Appel |
Arthritis & Rheumatism | 1982 |
The hypercalcemia of malignancy: Pathogenesis and management
GR Mundy, TJ Martin |
Metabolism | 1982 |
Multiples Myelom
H Ludwig |
1982 | |
Purification and partial characterization of a protein from cancer ascites fluid which stimulates the resorption of bone explants in vitro
RB Nimberg, DE Humphries, WS Lloyd, H Wells, K Schmid |
The Journal of biological chemistry | 1982 |
Observations on the mechanism of bone resorption induced by multiple myeloma marrow culture fluids and partially purified osteoclast-activating factor
RG Josse, TM Murray, GR Mundy, D Jez, JN Heersche |
Journal of Clinical Investigation | 1981 |
Protein synthesis in rheumatoid synovial tissue
JD Smiley, WL Hoffman |
Springer Seminars in Immunopathology | 1981 |
Human parathyroid hormone 1-34-mediated hypercalcemia in a rat model, and its inhibition by dichloromethane diphosphonate
SH Doppelt, RM Neer, JT Potts |
Calcified Tissue International | 1981 |
Relation of Osteoclast Activating Factor Production to Extent of Bone Disease in Multiple Myeloma
BG Durie, SE Salmon, GR Mundy |
British Journal of Haematology | 1981 |
Primary squamous cell carcinoma of the thyroid associated with marked leukocytosis and hypercalcemia
K Saito, Y Kuratomi, K Yamamoto, T Saito, T Kuzuya, S Yoshida, SI Moriyama, A Takahashi |
Cancer | 1981 |
Lymphokine-mediated bone resorption requires endogenous prostaglandin synthesis
RS Bockman, MA Repo |
Journal of Experimental Medicine | 1981 |
Demonstration and preliminary characterization of bone resorbing activity in freeze-dried gingiva of dogs
RM Hopps, K Nuki, LG Raisz |
Calcified Tissue International | 1980 |
Effects of a bone resorptive factor from human cancer ascites fluid on rat bone cell calcium and cyclic AMP
R Dziak, YW Chang, D Humphries, W Lloyd, H Wells, K Schmid, RB Nimberg |
Calcified Tissue International | 1980 |
Skeletal Scintigraphy with Technetium Diphosphonate in Multiple Myeloma-a Comparison with Skeletal X-Ray
E Lindström, FD Lindström |
Acta Medica Scandinavica | 1980 |
Cell-mediated immunity to collagen and collagen α chains in rheumatoid arthritis and other rheumatic diseases
JM Stuart, AE Postlethwaite, AS Townes, AH Kang |
The American Journal of Medicine | 1980 |
Progress in Myeloma
M Vrana, PA Bunn |
Progress in Myeloma | 1980 |
An assay for osteoclast-activating factor (OAF) in biological fluids: Detection of OAF in the serum of myeloma patients
RA Luben |
Cellular Immunology | 1980 |
Hypercalcaemia in malignant lymphoma
M Greaves, BW Hancock |
Postgraduate medical journal | 1980 |
Production of hybridomas secreting monoclonal antibodies against the lympholine osteoclast activating factor
RA Luben, MA Mohler, GE Nedwin |
Journal of Clinical Investigation | 1979 |
Effects of osteoclast activating factor from human lymphocytes on cyclic AMP concentrations in isolated mouse bone and bone cells
RA Luben, MC Chen, DM Rosen, MA Mohler |
Calcified Tissue International | 1979 |
Partial purification of a bone-resorbing factor elaborated from human allogeneic cultures
JE Horton, WJ Koopman, JJ Farrar, J Fuller-Bonar, SE Mergenhagen |
Cellular Immunology | 1979 |
Skeletal Research: an Experimental Approach
EA Tonna |
Skeletal Research: an Experimental Approach | 1979 |
The Hypercalcemia of Genitourinary Malignancy
JD Lubensky, MP Gangai |
The Journal of Urology | 1979 |
A bone resorbing substance from bovine serum albumin (brA)
PH Stern, JC Miller, SF Chen, DJ Kahn |
Calcified Tissue Research | 1978 |
Mechanisms of hypercalcemia in malignancy
A Besarab, JF Caro |
Cancer | 1978 |
Primary hyperparathyroidism and chronic lymphocytic leukemia
JC Wang, W Steier, MK Aung, MS Tobin |
Cancer | 1978 |
The pathophysiology and clinical aspects of hypercalcemic disorders
DB Lee, ET Zawada, CR Kleeman |
The Western journal of medicine | 1978 |
Pathogenesis of hypercalcemia in lymphosarcoma cell leukemia
GR Mundy, ME Rick, R Turcotte, MA Kowalski |
The American Journal of Medicine | 1978 |
Hypercalcemic crisis associated with the hypereosinophilic syndrome
JE Gittman, G Schneider, RE Carnes, YS Arkel |
The American Journal of Medicine | 1978 |
Purification of a lymphokine: Osteoclast activating factor from human tonsil lymphocytes
RA Luben |
Biochemical and Biophysical Research Communications | 1978 |
Calcium Urolithiasis
CY Pak |
1978 | |
Big and Little Forms of Osteoclast Activating Factor
GR Mundy, LG Raisz, JL Shapiro, JG Bandelin, RJ Turcotte |
Journal of Clinical Investigation | 1977 |
Phytomitogen-induced, lymphokine-mediated cartilage proteoglycan degradation
JH Herman, DS Musgrave, MV Dennis |
Arthritis & Rheumatism | 1977 |
Studies on congenital osteopetrosis in microphthalmic mice using organ cultures: impairment of bone resorption in response to physiologic stimulators
LG Raisz, HA Simmons, SC Gworek, G Eilon |
Journal of Experimental Medicine | 1977 |
Studies on the pathogenesis of cancer hypercalcemia
WP Myers, R Bockman |
Transactions of the American Clinical and Climatological Association | 1977 |
Acute myelofibrosis and malignant hypercalcemia
JA Libnoch, K Ajlouni, WL Millman, AR Guansing, GB Theil |
The American Journal of Medicine | 1977 |
Metabolic Bone Disease
OL Bijvoet |
Metabolic Bone Disease | 1977 |
Production of osteoclast-activating factor by normal human peripheral blood rosetting and nonrosetting lymphocytes
P Chen, C Trummel, J Horton, JJ Baker, JJ Oppenheim |
European Journal of Immunology | 1976 |
Recent insights into the pathogenesis of the proliferative lesion in rheumatoid arthritis
ED Harris |
Arthritis & Rheumatism | 1976 |
Human breast tumour-induced osteolysis and prostaglandins
M Dowsett, GC Easty, TJ Powles, DM Easty, AM Neville |
Prostaglandins | 1976 |
Serum parathyroid hormone levels and serum calcium levels from birth to senescence
BS Roof, CF Piel, J Hansen, HH Fudenberg |
Mechanisms of Ageing and Development | 1976 |
Hypercalcemia and Malignancy
DA Heath |
Annals of Clinical Biochemistry | 1976 |
The Year in Endocrinology, 1975–1976
SH Ingbar |
1976 | |
Effect of osteoclast activating factor from human leukocytes on bone metabolism
LG Raisz, RA Luben, GR Mundy, JW Dietrich, JE Horton, CL Trummel |
Journal of Clinical Investigation | 1975 |
LYMPHOKINES IN RHEUMATOID SYNOVITIS
P Stastny, M Rosenthal, M Andreis, D Cooke, M Ziff |
Annals of the New York Academy of Sciences | 1975 |
THE ROLE OF LYMPHOCYTES AND MACROPHAGES IN THE DESTRUCTION OF BONE AND COLLAGEN
SE Mergenhagen, SM Wahl, LM Wahl, JE Horton, LG Raisz |
Annals of the New York Academy of Sciences | 1975 |
Hypercalcaemia in Chronic Lymphatic Leukaemia
K Norrby, O Vikrot |
Scandinavian Journal of Haematology | 1975 |
Evidence for the Secretion of an Osteoclast Stimulating Factor in Myeloma
GR Mundy, LG Raisz, RA Cooper, GP Schechter, SE Salmon |
New England Journal of Medicine | 1974 |
Osteoclastic Bone Resorption and the Hypercalcemia of Cancer
HB Brewer |
New England Journal of Medicine | 1974 |